Annual meeting 2014
The annual meeting and post-ICAAC symposium took place on September 9th, 2014, 2:00-6:00 pm, Hemsley Fraser, Suite 900, 1615 M Street, NW, 20036 Washington DC, MD
Program:
Scientific presentations by junior investigators
Online presentations (will be posted after ICAAC):
Download program
Program:
| 12:00 - 1:00 pm 1:00 - 1:45 pm |
ISAP Council Meeting ISAP General Meeting |
2:00 – 2:10 pm |
Welcome |
| 2:10 – 3:10 pm |
Scientific presentation and discussion PK/PD in the regulatory environment Joga Gobburu, University of Maryland, School of Pharmacy, former head of pharmacometrics at FDA |
| 3:10 - 3:40 pm |
Break / informal discussion |
| 3:40 – 5:40 pm |
Scientific presentations by junior investigators |
| 5:40- 6:00 pm |
Discussion and closing remarks |
Scientific presentations by junior investigators
| MW. Sadiq | A whole-body physiologically based pharmacokinetic model of ciprofloxacin for prediction of bacterial killing at the site of infection |
| S. Aitken | Cefepime free minimum concentration to minimum inhibitory concentration ratio predicts clinical failure in patients with Gram-negative bacterial pneumonia |
| T-P. Lim | Multiple combination bactericidal testing-guided therapy is effective in the treatment of extensively drug-resistant Gram-negative bacteria infections |
| E. Bassères | Antibiotic activity against different Pseudomonas aeruginosa phenotypes in an artificial sputum medium biofilm model |
| A. Sultan | Bayesian estimation of levofloxacin pharmacokinetics in patients with tuberculosis |
Online presentations (will be posted after ICAAC):
| A. Deitchman | The synergism between tigecycline and tetracycline: A protein binding-based approach |
| S. Wicha | Pharmacodynamics of vancomycin or linezolid combined with meropenem against Staphylococcus aureus assessed by descriptive and semi-mechanistic modelling techniques |
Download program